Magen OrthoMed Ltd
|Company:||Magen OrthoMed Ltd|
|Mobile:||+972 52 490709|
|Technology Classification:||Medical Devices|
|Main Business Activity:||Medical Devices - Orthopedics|
Company Profile, Products & Technologies, Target Market:
Magen OrthoMed Ltd. is developing game-changing removable adhesion barriers for the multi-billion dollar orthopedic market.
The Millennium Research Group estimates the cost of treating adhesiolysis (the surgical removal of adhesions) for all surgical indications in the US as being over $2 billion annually.
The company is developing three proprietary products:
1. SpineShield - Post laminectomy Adhesion Barrier Device
The SpineShield is a removable adhesion barrier that separates and provides a gap between spinal nerves and adhesions.
2.TendonShield - Post Peripheral Tendon Surgery Adhesion Barrier Device
The TendonShield protects peripheral tendons from scar tissue formation in surgeries involving the suture of tendons, as post-surgical adhesions can prevent smooth movement following surgery.
3. NerveShield - Post Peripheral Nerves Surgery Adhesion Barrier Device
The NerveShield protects scar tissue formation around peripheral nerves induced by trauma following.
Brief description of proposed R&D project:
The proposed R&D project is to finalize the engineering development of the SpineShield - Post laminectomy Adhesion Barrier Removable Device and to conduct a thorough clinical trial to study its efficacy.
The main R&D activities:
- Finalize design
- CE approvals
- Clinical trials
Role of Requesting Company in Proposed R&D Project:
Magen OrthoMed shall be responsible for the engineering development of the SpineShield as well as for the pre-regulatory activities such as the medical V&V (validation and verification) studies.
Desired Profile of R&D Partner and its role in the proposed project:
A leading medical research institution such as a university medical center that is possessing an active spine unit that is interested in the development of breakthrough technologies.